CClinicalTrials.gg
CompletedNCT03327376DUCTUpdated Oct 24, 2022

Daily Ultrasound-screening for CVC-related Thrombosis

An observational study in Central Venous Catheter Thrombosis, Critical Illness and Ultrasonography, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-10-24.

Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,262
Ages
18 Years and older
Sex
All
01

Study summary

The central venous catheters (CVC) related thrombosis is an issue of importance to ICU clinicians.This study conducts the daily ultrasound-screening for CVC-related thrombosis (DUCT).Its aim is to evaluate the characteristic and regularity of the central venous catheters (CVC) related thrombosis in ICU patients, and optimize the screening program of CVC-related thrombosis.

02

Conditions studied

  • Central Venous Catheter Thrombosis
  • Critical Illness
  • Ultrasonography

Keywords

  • central venous catheters
  • venous thrombosis
  • ultrasound
  • critical care
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

We conduct an observational prospective multicenter study.The patients come from the ICUs of Zhejiang province.

Inclusion criteria

  • Consecutive patients at least 18 years of age, expected to need a central venous catheterization for at least 48h in ICU.

Exclusion criteria

Exclusion Criteria:

  • Patients with infection or inflammation or local trauma at the insertion site.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,262 participants (actual)
Patient registry
No

Groups and cohorts

  • Characteristic and regularity of CRT

    The patients who have a central venous catheterization conduct the daily ultrasound-screening for CVC-related Thrombosis (DUCT).

    Device: ultrasound-screening

Interventions

  • Deviceultrasound-screening

    Daily ultrasound-screening for CVC-related thrombosis (DUCT) by compression ultrasound and color doppler ultrasound.

05

What researchers measure

Primary outcomes

  1. the incidence rate of central venous catheters related thrombosis (CRT)

    the percentage of patients who have CRT in all patients included.

    Time frame: the assessment time will be from the time patients admitted in ICU to the time leaving ICU, less than 6 months.

Secondary outcomes

  1. the time when the central venous catheters related thrombosis (CRT) occured

    which day the CRT is found after central venous catheter.

    Time frame: the assessment time will be from the time patients admitted in ICU to the time leaving ICU, less than 6 months.

06

Study locations

1 site
  • 2nd Affiliated Hospital, Zhejiang University School of Medicine Institute of Emergency Medicine, Zhejiang University
    Hanzhou, Zhejiang 310009, China
07

References and documents

Publications

  • Faustino EV, Spinella PC, Li S, Pinto MG, Stoltz P, Tala J, Card ME, Northrup V, Baker KE, Goodman TR, Chen L, Silva CT. Incidence and acute complications of asymptomatic central venous catheter-related deep venous thrombosis in critically ill children. J Pediatr. 2013 Feb;162(2):387-91. doi: 10.1016/j.jpeds.2012.06.059. Epub 2012 Aug 9. PubMed 22883418 ↗
  • Lee AY, Kamphuisen PW. Epidemiology and prevention of catheter-related thrombosis in patients with cancer. J Thromb Haemost. 2012 Aug;10(8):1491-9. doi: 10.1111/j.1538-7836.2012.04817.x. PubMed 22703114 ↗
  • Refaei M, Fernandes B, Brandwein J, Goodyear MD, Pokhrel A, Wu C. Incidence of catheter-related thrombosis in acute leukemia patients: a comparative, retrospective study of the safety of peripherally inserted vs. centrally inserted central venous catheters. Ann Hematol. 2016 Dec;95(12):2057-2064. doi: 10.1007/s00277-016-2798-4. Epub 2016 Aug 20. PubMed 27542955 ↗
  • Parienti JJ, Mongardon N, Megarbane B, Mira JP, Kalfon P, Gros A, Marque S, Thuong M, Pottier V, Ramakers M, Savary B, Seguin A, Valette X, Terzi N, Sauneuf B, Cattoir V, Mermel LA, du Cheyron D; 3SITES Study Group. Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med. 2015 Sep 24;373(13):1220-9. doi: 10.1056/NEJMoa1500964. PubMed 26398070 ↗
  • Gentile A, Petit L, Masson F, Cottenceau V, Bertrand-Barat J, Freyburger G, Pinaquy C, Leger A, Cochard JF, Sztark F. Subclavian central venous catheter-related thrombosis in trauma patients: incidence, risk factors and influence of polyurethane type. Crit Care. 2013 May 29;17(3):R103. doi: 10.1186/cc12748. PubMed 23718723 ↗

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT03327376
Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible party
Sponsor
First posted
Oct 31, 2017
Start date
Dec 1, 2017
Primary completion
Jan 1, 2022
Completion
Jan 1, 2022
Last update
Oct 24, 2022

Study contacts

Mao Zhang, MD
study director · 2nd Affiliated Hospital, Zhejiang University School of Medicine Institute of Emergency Medicine, Zhejiang University
Weidong Tang, MD
principal investigator · The First People's Hospital of Fuyang District
Zhiping Huang, MD
principal investigator · Beilun District People's Hospital
Zhaohui Ji, MD
principal investigator · The First People's Hospital of Huzhou
Hong Liu, MD
principal investigator · Lishui Country People's Hospital
Lingcong Wang, MD
principal investigator · The First Affiliated Hospital of Zhejiang University of traditional Chinese Medicine
Mingwei Huang, MD
principal investigator · Jinhua Central Hospital
Xingwen Zhang, MD
principal investigator · Hunan People's Hospital
Yunchao Shi, MD
principal investigator · Affiliated Hospital of Jiaxing University
Renfei Shan, MD
principal investigator · Taizhou Hospital
Fuzheng Tao, MD
principal investigator · Taizhou Hospital of integrated traditional Chinese and Western Medicine
Yi Wang, MD
principal investigator · First People's Hospital of Hangzhou
Qijiang Chen, MD
principal investigator · Ninghai First Hospital
Ning Zhang, MD
principal investigator · Lishui Country People's Hospital
Jian Hu, MD
principal investigator · Pinghu first people's Hospital
Dengpan Lai, MD
principal investigator · Affiliated Hospital of Hangzhou Teacher's University
Yingru Lu, MD
principal investigator · First Affiliated Hospital of Wenzhou Medical University
Xudong Zheng, MD
principal investigator · Ruian People's Hospital
Jianbo Gao, MD
principal investigator · The First People's Hospital of Fuyang District
Bei Tang, MD
principal investigator · Jiande First People's Hospital
Wansheng Li, MD
principal investigator · Taizhou Hospital
Xiaoyuan Shen, MD
principal investigator · Xiaoshan first people's Hospital
Yukang Song, MD
principal investigator · Affiliated Wenling Hospital of Wenzhou Medical University
Guojuan Ding, MD
principal investigator · Shaoxing People's Hospital
Feng Wu, MD
principal investigator · Zhejiang Quhua Hospital
Xin Tian, MD
principal investigator · The Central Hospital of Lishui City
Shaoyi Xu, MD
principal investigator · The Second Affiliated Hospital of Jiaxing University
Weijun Fang, MD
principal investigator · The Central Hospital of Lishui City
LIfeng Wu, MD
principal investigator · Yuyao People's Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion